Elevation Pharmaceuticals
Elevation Pharmaceuticals was a San Diego specialty pharmaceutical company founded in 2008 by Cam Garner, Bill Gerhart, and Ahmet Tutuncu to develop next-generation aerosol/inhalation therapies for chronic obstructive pulmonary disease (COPD). It raised a $30 million Series A in 2010 backed by Canaan Partners, TPG Growth, Care Capital, and Mesa Verde Venture Partners, and was acquired by Sunovion Pharmaceuticals in August 2012. The company is no longer independently operating; its domain now resolves to Sunovion nameservers and it publishes no public API, developer portal, or developer surface. This profile is retained in the API Evangelist network as a Canaan Partners portfolio record.
Elevation Pharmaceuticals is profiled on the APIs.io network. Tagged areas include Company, Pharmaceuticals, Biotech, COPD, and Respiratory.